Acceleron Pharma (XLRN) Upgraded to Buy by Zacks Investment Research – Rockland Register
Acceleron Pharma (XLRN) Upgraded to Buy by Zacks Investment Research Rockland Register
Zacks Investment Research upgraded shares of Acceleron Pharma (NASDAQ:XLRN) from a hold rating to a buy rating in a research report sent to investors on …
Source: Investment New Feed